基于证据的持续性肺高血压的管理
1Children's Mercy Hospitals and Clinics, Kansas City, MO, USA carolrtrees@gmail.com.
Neonatal network : NN
|February 26, 2026
概括
新生儿持续性肺高血压 (PPHN) 的管理是复杂的. 基于证据的干预包在NICU可以改善婴儿稳定和减少转移.
科学领域:
- 新生儿医学 新生儿医学
- 儿童心脏病学 儿童心脏病学
- 关键的护理关键的护理
背景情况:
- 新生儿持续性肺高血压 (PPHN) 涉及肺血管阻力升高和胎儿血液循环过渡受损.
- 由于复杂,多因素的病理生理学,管理PPHN具有挑战性.
- 缺乏临床共识和正式指导方针使PPHN护理复杂化.
研究的目的:
- 提出一个全面的,基于证据的PPHN管理方法.
- 探索III级NICU干预包的潜在好处.
主要方法:
- 对PPHN干预措施的现有文献的审查.
- 拟议的一组基于证据的干预措施的开发.
- 专注于III级新生儿重症监护病房 (NICU) 的应用.
主要成果:
- 对于患有PPHN的重症新生儿,全面的方法是必不可少的.
- 基于证据的干预包可以增强婴儿稳定.
- 在III级NICU的实施可能会减少向IV级NICU的转移.
结论:
- 一个标准化,基于证据的护理包对于PPHN管理至关重要.
- 实施此类捆绑可能会改善高风险新生儿的结果.
- 这种方法可以优化跨NICU级别的资源利用.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
596
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
596
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
552
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
552
Pulmonary Hypertension: Classification and Pathogenesis
721
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
721
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
680
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
680
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.4K


